Remote Neuropsychological Testing
Center of Accessible Neuropsychology is researching how different parts of the brain contribute to cognitive processes such as language, mathematics, learning, and emotions. They ask if there is a relationship between cognitive processes and self-reported medical assessment.
Link to enroll: tinyurl.com/yvh2ttdh
About the Study
Eligible Ataxia Types
Spinocerebellar Ataxia and Cerebellar Degeneration (any subtype)
Type of Study
Research Study
Clinical Trial Phase
N/A
Age Range
Children and Adult 18+
Study Start Date
07/07/2023
Estimated Completion Date
07/07/2025
IRB Approval #
0006500-1
Location(s)
Faculty of Medicine, Center for Accessible Neuropsychology
Remote Study
www.sabcan.sites.tau.ac.il/participate
Contact Information
Dr. William Saban
Email: can@tauex.tau.ac.il
What does participation in the study entail?
The study will be conducted online in coordination with the researchers and can be completed from your computer whenever it is convenient for you. The study involves filling out questionnaire/s and performing short tasks, such as pressing buttons in response to stimuli appearing on the computer screen. These tasks can include solving math equations, pressing keys in a specific order, or choosing if a sequence of letters follows a rule or not.
What are the potential benefits for participants?
We hope that this study will prove beneficial by increasing our knowledge of how cognition is processed in the brain.
What are the potential risks for participants?
There are no risks for participants. This research will not interfere with any medical treatment, nor is there any direct benefit to you.
Is there financial compensation?
Yes. $15/hour
Is there travel reimbursement?
No. Not applicable.
Who is eligible?
Spinocerebellar Ataxia and Cerebellar Degeneration (any subtype)
View Other Research Opportunities
Evaluation of At-Home Wrist and Ankle Wearable Sensors to Produce Sensitive and Functionally Relevant Digital Outcome Measures in Spinocerebellar Ataxia Types 3 and 2
To evaluate the sensitivity and meaningfulness of wearables-based outcome measures in a dedicated study in SCA2 and SCA3. The purpose of the wearable device is to accurately measure the movement Read More…
To Test or Not to Test: Exploring Predictive Genetic Testing Decision Making in Individuals with a Family History of Hereditary Ataxia
Our research goal is to further explore the factors influencing participants’ predictive genetic testing decision-making for hereditary ataxia. We will achieve this by interviewing participants who declined genetic testing as Read More…
Monogenic and Polygenic Risk Prediction for Individuals
MyOme Inc. is a health technology company focused on using genetic testing to help people understand their health risks before problems start. In this study, MyOme is testing a new Read More…
